US 10933066
Methods and compositions for treatment of Zika virus infection
granted A61KA61K31/519A61K45/06
Quick answer
US patent 10933066 (Methods and compositions for treatment of Zika virus infection) held by BioCryst Pharmaceuticals, Inc. expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BioCryst Pharmaceuticals, Inc.
- Grant date
- Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/519, A61K45/06, A61K9/0019, A61K9/0053